Pragmatic Considerations for the Application of Physical Withdrawal Assessments in Patient Studies

Getting to the Heart of Science with Sophie Dubois



The Stories That Inspire

In this video, our very own Sophie Dubois shares what led her to Altasciences and how the company’s core values and mission of helping to improve lives resonate with her.

 


Struggling With Solubility or Bioavailability Challenges?



Trust the Right Formulation Partner.

Altasciences’ scientists have formulated and developed countless molecules using various advanced technologies. We solve the most complex solubility and bioavailability challenges using superior, data-driven technologies, such as nanomilling.

Our full range of pharmaceutical formulation services can improve the quality and performance of your product, for a seamless transition from discovery to clinical trials to market.

Ready to start? Speak with one of our experts, and let us help you deliver better treatments to patients who need them, faster.

Related resources that may interest you:

Ashley joined Altasciences in 2022 as Study Director.

Ecm85, CC BY-SA 3.0 <http://creativecommons.org/licenses/by-sa/3.0/>, via Wikimedia Commons
Ecm85, CC BY-SA 3.0 via Wikimedia Commons

My fellow Altascientists and I recently attended the 2024 annual Boston Society Gen

The Next Generation of Non-Rodent Species for Nonclinical Studies


Embracing Change

If you missed our latest webinar in collaboration with Sinclair Bio Resources, The Next Generation Non-Rodent Model for (Bio)Pharmaceuticals Safety Assessment, it’s not too late! The on-demand version is now available.

You’ll learn about the increasing role of miniature swine in drug development and the distinct advantages offered by the Sinclair Nanopig™ model—from availability across all ages to comparable toxicological data with Göttingen™ minipigs and other non-rodent species.

Watch it now!

​​​​

Sinclair Nanopig

If you have questions about your nonclinical studies, speak with one of our experts.

You may also be interested in:


Subscribe to